EmbolizationInterventional Oncology and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Embolization in Interventional Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Embolization in Interventional Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Embolization in Interventional Oncology Overall Market Size
2.1 Global Embolization in Interventional Oncology Market Size: 2021 VS 2028
2.2 Global Embolization in Interventional Oncology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Embolization in Interventional Oncology Players in Global Market
3.2 Top Global Embolization in Interventional Oncology Companies Ranked by Revenue
3.3 Global Embolization in Interventional Oncology Revenue by Companies
3.4 Top 3 and Top 5 Embolization in Interventional Oncology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Embolization in Interventional Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Embolization in Interventional Oncology Players in Global Market
3.6.1 List of Global Tier 1 Embolization in Interventional Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Embolization in Interventional Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Embolization in Interventional Oncology Market Size Markets, 2021 & 2028
4.1.2 Embolization Devices
4.1.3 Ablation Devices
4.1.4 Support Devices
4.2 By Type - Global Embolization in Interventional Oncology Revenue & Forecasts
4.2.1 By Type - Global Embolization in Interventional Oncology Revenue, 2017-2022
4.2.2 By Type - Global Embolization in Interventional Oncology Revenue, 2023-2028
4.2.3 By Type - Global Embolization in Interventional Oncology Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Embolization in Interventional Oncology Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Embolization in Interventional Oncology Revenue & Forecasts
5.2.1 By Application - Global Embolization in Interventional Oncology Revenue, 2017-2022
5.2.2 By Application - Global Embolization in Interventional Oncology Revenue, 2023-2028
5.2.3 By Application - Global Embolization in Interventional Oncology Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Embolization in Interventional Oncology Market Size, 2021 & 2028
6.2 By Region - Global Embolization in Interventional Oncology Revenue & Forecasts
6.2.1 By Region - Global Embolization in Interventional Oncology Revenue, 2017-2022
6.2.2 By Region - Global Embolization in Interventional Oncology Revenue, 2023-2028
6.2.3 By Region - Global Embolization in Interventional Oncology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Embolization in Interventional Oncology Revenue, 2017-2028
6.3.2 US Embolization in Interventional Oncology Market Size, 2017-2028
6.3.3 Canada Embolization in Interventional Oncology Market Size, 2017-2028
6.3.4 Mexico Embolization in Interventional Oncology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Embolization in Interventional Oncology Revenue, 2017-2028
6.4.2 Germany Embolization in Interventional Oncology Market Size, 2017-2028
6.4.3 France Embolization in Interventional Oncology Market Size, 2017-2028
6.4.4 U.K. Embolization in Interventional Oncology Market Size, 2017-2028
6.4.5 Italy Embolization in Interventional Oncology Market Size, 2017-2028
6.4.6 Russia Embolization in Interventional Oncology Market Size, 2017-2028
6.4.7 Nordic Countries Embolization in Interventional Oncology Market Size, 2017-2028
6.4.8 Benelux Embolization in Interventional Oncology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Embolization in Interventional Oncology Revenue, 2017-2028
6.5.2 China Embolization in Interventional Oncology Market Size, 2017-2028
6.5.3 Japan Embolization in Interventional Oncology Market Size, 2017-2028
6.5.4 South Korea Embolization in Interventional Oncology Market Size, 2017-2028
6.5.5 Southeast Asia Embolization in Interventional Oncology Market Size, 2017-2028
6.5.6 India Embolization in Interventional Oncology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Embolization in Interventional Oncology Revenue, 2017-2028
6.6.2 Brazil Embolization in Interventional Oncology Market Size, 2017-2028
6.6.3 Argentina Embolization in Interventional Oncology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Embolization in Interventional Oncology Revenue, 2017-2028
6.7.2 Turkey Embolization in Interventional Oncology Market Size, 2017-2028
6.7.3 Israel Embolization in Interventional Oncology Market Size, 2017-2028
6.7.4 Saudi Arabia Embolization in Interventional Oncology Market Size, 2017-2028
6.7.5 UAE Embolization in Interventional Oncology Market Size, 2017-2028
7 Players Profiles
7.1 Braile Biomedica
7.1.1 Braile Biomedica Corporate Summary
7.1.2 Braile Biomedica Business Overview
7.1.3 Braile Biomedica Embolization in Interventional Oncology Major Product Offerings
7.1.4 Braile Biomedica Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.1.5 Braile Biomedica Key News
7.2 Boston Scientific
7.2.1 Boston Scientific Corporate Summary
7.2.2 Boston Scientific Business Overview
7.2.3 Boston Scientific Embolization in Interventional Oncology Major Product Offerings
7.2.4 Boston Scientific Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.2.5 Boston Scientific Key News
7.3 Cook Medical
7.3.1 Cook Medical Corporate Summary
7.3.2 Cook Medical Business Overview
7.3.3 Cook Medical Embolization in Interventional Oncology Major Product Offerings
7.3.4 Cook Medical Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.3.5 Cook Medical Key News
7.4 Covidien
7.4.1 Covidien Corporate Summary
7.4.2 Covidien Business Overview
7.4.3 Covidien Embolization in Interventional Oncology Major Product Offerings
7.4.4 Covidien Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.4.5 Covidien Key News
7.5 Merit Medical Systems, Inc.
7.5.1 Merit Medical Systems, Inc. Corporate Summary
7.5.2 Merit Medical Systems, Inc. Business Overview
7.5.3 Merit Medical Systems, Inc. Embolization in Interventional Oncology Major Product Offerings
7.5.4 Merit Medical Systems, Inc. Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.5.5 Merit Medical Systems, Inc. Key News
7.6 Penumbra
7.6.1 Penumbra Corporate Summary
7.6.2 Penumbra Business Overview
7.6.3 Penumbra Embolization in Interventional Oncology Major Product Offerings
7.6.4 Penumbra Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.6.5 Penumbra Key News
7.7 TERUMO MEDICAL CORPORATION
7.7.1 TERUMO MEDICAL CORPORATION Corporate Summary
7.7.2 TERUMO MEDICAL CORPORATION Business Overview
7.7.3 TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Major Product Offerings
7.7.4 TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.7.5 TERUMO MEDICAL CORPORATION Key News
7.8 Stryker
7.8.1 Stryker Corporate Summary
7.8.2 Stryker Business Overview
7.8.3 Stryker Embolization in Interventional Oncology Major Product Offerings
7.8.4 Stryker Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.8.5 Stryker Key News
7.9 Terumo
7.9.1 Terumo Corporate Summary
7.9.2 Terumo Business Overview
7.9.3 Terumo Embolization in Interventional Oncology Major Product Offerings
7.9.4 Terumo Embolization in Interventional Oncology Revenue in Global Market (2017-2022)
7.9.5 Terumo Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Embolization in Interventional Oncology Market Opportunities & Trends in Global Market
Table 2. Embolization in Interventional Oncology Market Drivers in Global Market
Table 3. Embolization in Interventional Oncology Market Restraints in Global Market
Table 4. Key Players of Embolization in Interventional Oncology in Global Market
Table 5. Top Embolization in Interventional Oncology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Embolization in Interventional Oncology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Embolization in Interventional Oncology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Embolization in Interventional Oncology Product Type
Table 9. List of Global Tier 1 Embolization in Interventional Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Embolization in Interventional Oncology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Embolization in Interventional Oncology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Embolization in Interventional Oncology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Embolization in Interventional Oncology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Embolization in Interventional Oncology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Embolization in Interventional Oncology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Embolization in Interventional Oncology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Embolization in Interventional Oncology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Embolization in Interventional Oncology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Embolization in Interventional Oncology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Embolization in Interventional Oncology Revenue, (US$, Mn), 2023-2028
Table 30. Braile Biomedica Corporate Summary
Table 31. Braile Biomedica Embolization in Interventional Oncology Product Offerings
Table 32. Braile Biomedica Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 33. Boston Scientific Corporate Summary
Table 34. Boston Scientific Embolization in Interventional Oncology Product Offerings
Table 35. Boston Scientific Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 36. Cook Medical Corporate Summary
Table 37. Cook Medical Embolization in Interventional Oncology Product Offerings
Table 38. Cook Medical Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 39. Covidien Corporate Summary
Table 40. Covidien Embolization in Interventional Oncology Product Offerings
Table 41. Covidien Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 42. Merit Medical Systems, Inc. Corporate Summary
Table 43. Merit Medical Systems, Inc. Embolization in Interventional Oncology Product Offerings
Table 44. Merit Medical Systems, Inc. Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 45. Penumbra Corporate Summary
Table 46. Penumbra Embolization in Interventional Oncology Product Offerings
Table 47. Penumbra Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 48. TERUMO MEDICAL CORPORATION Corporate Summary
Table 49. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Product Offerings
Table 50. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 51. Stryker Corporate Summary
Table 52. Stryker Embolization in Interventional Oncology Product Offerings
Table 53. Stryker Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
Table 54. Terumo Corporate Summary
Table 55. Terumo Embolization in Interventional Oncology Product Offerings
Table 56. Terumo Embolization in Interventional Oncology Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Embolization in Interventional Oncology Segment by Type in 2021
Figure 2. Embolization in Interventional Oncology Segment by Application in 2021
Figure 3. Global Embolization in Interventional Oncology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Embolization in Interventional Oncology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Embolization in Interventional Oncology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Embolization in Interventional Oncology Revenue in 2021
Figure 8. By Type - Global Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 12. US Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 16. Germany Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 17. France Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 24. China Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 28. India Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 30. Brazil Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Embolization in Interventional Oncology Revenue Market Share, 2017-2028
Figure 33. Turkey Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Embolization in Interventional Oncology Revenue, (US$, Mn), 2017-2028
Figure 37. Braile Biomedica Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boston Scientific Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cook Medical Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Covidien Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merit Medical Systems, Inc. Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Penumbra Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Stryker Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Terumo Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
